- Home
- ICLR vs AES Comparison
ICLR vs AES Comparison
Compare ICLR & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICLR | AES |
|---|---|---|
| Founded | 1990 | 1981 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.9B |
| IPO Year | 2001 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ICLR | AES |
|---|---|---|
| Price | $146.18 | $14.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 10 |
| Target Price | ★ $178.62 | $15.29 |
| AVG Volume (30 Days) | 1.1M | ★ 8.4M |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $12,233,000,000.00 |
| Revenue This Year | N/A | $5.22 |
| Revenue Next Year | N/A | $4.81 |
| P/E Ratio | ★ $12.91 | $21.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $66.57 | $10.02 |
| 52 Week High | $211.00 | $17.65 |
Technical Indicators
Market Signals| Indicator | ICLR | AES |
|---|---|---|
| Relative Strength Index (RSI) | 63.32 | 58.40 |
| Support Level | $99.11 | $13.98 |
| Resistance Level | $188.03 | $15.02 |
| Average True Range (ATR) | 8.29 | 0.05 |
| MACD | 1.04 | -0.01 |
| Stochastic Oscillator | 77.73 | 54.17 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.